ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling

Wei Chen, Kellye C. Kirkbride, Tam How, +6

Science

CytoskeletonMediates EndocytosisCellular PhysiologyBeta-arrestin 2Signaling Pathway +15

The type III TGF-β receptor suppresses breast cancer progression

Mei Dong, Tam How, Kellye C. Kirkbride, +7

Journal of Clinical Investigation

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs

Dereje D. Jima, Jenny Zhang, Cassandra L. Jacobs, +31

Blood

A Novel Mechanism for Regulating Transforming Growth Factor β (TGF-β) Signaling

Gerard C. Blobe, Xuedong Liu, Shijing Fang, +2

Journal of Biological Chemistry

The Type III Transforming Growth Factor-β Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer

Ryan S. Turley, Elizabeth Finger, Nadine Hempel, +3

Cancer Research

Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion

Nadine Hempel, Tam How, Mei Dong, +3

Cancer Research

Ovarian Cancer MotilityOncologyMedicineCancer GrowthGynecology +9

Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2

Kelly J. Gordon, Kellye C. Kirkbride, Tam How, +1

Carcinogenesis

Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC

Nam Y. Lee, Bridgette N. Ray, Tam How, +1

Journal of Biological Chemistry

TβRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity

Elizabeth Finger, Ryan S. Turley, Mei Dong, +3

Carcinogenesis

Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development

Alisha Holtzhausen, Christelle Golzio, Tam How, +4

The FASEB Journal

SclerostinOsteoporosisTumor BiologyBone Morphogenetic ProteinTissue Development +18